Delivery Order SPE2DR25D2206-SPE2DR26F9CB3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,217.40 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on October 27, 2025. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of October 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,766.40 to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents. The contract is firm fixed price with no set-aside designation and was competitively awarded on August 29, 2025, with an ultimate completion date of September 2, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $6,287.40. The delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-set-aside competitive award. The vaccine will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations. This...
- The Defense Logistics Agency awarded a $1,257.48 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 15, 2025. The contract is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal government's medical supply needs through AmerisourceBergen's established vendor...
- The Defense Logistics Agency awarded a delivery order valued at $9,338.40 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, issued on November 13, 2025, with an ultimate completion date of November 14, 2025, represents a firm fixed-price procurement with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,882.23 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency has awarded a $15,829.83 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This is a firm fixed price, non-set-aside contract with a completion date of October 31, 2025, issued just one day before the award date. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,237.54 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This non-competitive delivery order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price purchase under the company's existing contract vehicle. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's medical...
- The Defense Logistics Agency awarded a $2,095.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rabavert rabies vaccine with diluents. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9CB3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,746.49 to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents. The award was made on November 17, 2025, with an ultimate completion date of November 18, 2025, under a firm fixed-price contract type with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical federal vendor for military and veteran healthcare systems, supplying a comprehensive range of pharmaceutical products and medical supplies including vaccines, medications, and specialized healthcare commodities. The company's prime IDC vehicle, designated SPE2DX, provides flexible pharmaceutical support to multiple federal customers including the Defense Health Agency and U.S. Coast Guard across military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 11/17/25 |